Related Experiment Videos

[Bacterial endocarditis and its relationships with obstructive hypertrophic cardiomyopathy and hepatic cirrhosis

Medicina Clinica
|April 25, 1981
PubMed

Insights

Bacterial endocarditis is rare in obstructive hypertrophic cardiomyopathy but can occur. This case highlights Staphylococcus aureus endocarditis in a cirrhotic patient, emphasizing the need for vigilance in high-risk populations.

Area of Science:

  • Cardiology
  • Infectious Diseases
  • Hepatology

Background:

  • Obstructive hypertrophic cardiomyopathy (oHCM) is a cardiac condition where bacterial endocarditis is an infrequent complication.
  • Cirrhotic patients may have a higher incidence of bacterial endocarditis, suggesting potential links to spontaneous bacterial peritonitis.
  • Pathologic examination of cardiac lesions in these cases is rare, limiting understanding of the association.

Observation:

  • A female patient with alcoholic liver cirrhosis and symptomatic obstructive hypertrophic cardiomyopathy developed bacterial endocarditis.
  • The endocarditis involved the mitral valve and was caused by Staphylococcus aureus.
  • The patient ultimately succumbed to infected ascites.

Findings:

  • The clinical presentation, responsible microorganisms, and prognosis of endocarditis in oHCM are generally similar to other forms of endocarditis.
  • This case provides rare pathological insight into bacterial endocarditis complicating obstructive hypertrophic cardiomyopathy in a cirrhotic patient.
  • The findings support the hypothesis of a hematogenous origin for spontaneous bacterial peritonitis in cirrhotic individuals.

Implications:

  • Increased awareness of bacterial endocarditis risk in patients with obstructive hypertrophic cardiomyopathy, particularly those with comorbidities like liver cirrhosis.
  • The case underscores the importance of considering Staphylococcus aureus as a causative agent in endocarditis within this patient group.
  • Further research into the mechanisms linking liver cirrhosis, obstructive hypertrophic cardiomyopathy, and bacterial endocarditis is warranted to improve patient outcomes.

Related Concept Videos